PLIANT THERAPEUTICS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Huh Hoyoung | — | C | 139,860 | — | — | 239,619 | Jun 5, 2020 |
| Cummings Keith Lamont | Chief Financial Officer | Option Exercise | 19,300 | $2.08 | $40,144 | 19,300 | Jun 5, 2020 |
| Howes Barbara | Chief Human Resource Officer | C | 3,821 | — | — | 24,799 | Jun 5, 2020 |
| TRV GP IV, LLC | — | C | 5,559,440 | — | — | 5,839,160 | Jun 5, 2020 |
| Exter Neil | — | C | — | — | — | — | Jun 5, 2020 |
| Green Jeremy | — | C | 1,910,657 | — | — | 1,910,657 | Jun 5, 2020 |
| Coulie Bernard | President and CEO | C | 25,397 | — | — | 474,317 | Apr 30, 2020 |